Annexon presented new geographic atrophy research at EURetina in Vienna, including Phase 2 ARCHER findings shared by Dr. Usha Chakravarthy. The update follows recent Phase 3 GA data and highlights its late-stage pipeline.
published
Annexon presented new geographic atrophy research at EURetina in Vienna, including Phase 2 ARCHER findings shared by Dr. Usha Chakravarthy. The update follows recent Phase 3 GA data and highlights its late-stage pipeline.
Latest documented BWB result
$NVDA market result
Exit $NVDA with $3 profit per share
Historical results are not a promise of future performance. Trading involves substantial risk.This public post is a timestamped information archive, not personalized financial advice. Alerts can change as markets move. Join Billy's private group for the complete daily stream and follow-through.